DI CARLO, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 4.155
EU - Europa 3.761
AS - Asia 2.405
SA - Sud America 175
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 10.512
Nazione #
US - Stati Uniti d'America 4.125
CN - Cina 840
UA - Ucraina 773
SG - Singapore 769
IE - Irlanda 629
TR - Turchia 557
GB - Regno Unito 494
IT - Italia 462
SE - Svezia 448
FR - Francia 368
DE - Germania 252
FI - Finlandia 152
BR - Brasile 149
IN - India 133
RU - Federazione Russa 118
VN - Vietnam 33
CA - Canada 18
HK - Hong Kong 17
BE - Belgio 14
AR - Argentina 11
AT - Austria 10
MX - Messico 10
PL - Polonia 9
IL - Israele 8
IQ - Iraq 8
NL - Olanda 8
CL - Cile 7
PK - Pakistan 6
CZ - Repubblica Ceca 5
EG - Egitto 5
ES - Italia 5
JP - Giappone 5
BD - Bangladesh 4
EU - Europa 4
RO - Romania 4
GR - Grecia 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
EC - Ecuador 2
TH - Thailandia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 10.512
Città #
Jacksonville 841
Chandler 702
Dublin 626
Singapore 455
Southend 387
Dearborn 382
Princeton 310
Izmir 264
Nanjing 251
Wilmington 173
Beijing 140
Cambridge 140
The Dalles 131
Altamura 98
Nanchang 78
Ann Arbor 73
New York 72
Santa Clara 71
Boardman 69
Chieti 60
Woodbridge 54
Shenyang 47
Pescara 45
Ashburn 43
Hebei 39
Romola 37
Kunming 36
Grevenbroich 34
Dong Ket 32
Jiaxing 30
Los Angeles 28
Tianjin 26
Hefei 21
Hangzhou 20
Houston 20
Jinan 19
Norwalk 18
Düsseldorf 17
Hong Kong 17
Orange 16
Changsha 15
Guangzhou 15
São Paulo 15
Helsinki 13
Chennai 12
Lanciano 12
Brussels 11
Falls Church 11
Auburn Hills 10
Camerino 10
Augusta 9
Leawood 9
Nuremberg 9
San Francisco 9
Toronto 9
Washington 9
Changchun 8
Lanzhou 8
Ningbo 8
San Mateo 8
Milan 7
Munich 7
Warsaw 7
Zhengzhou 7
Baghdad 6
Mexico City 6
Shanghai 6
Tappahannock 6
Bari 5
Boston 5
Brooklyn 5
Manchester 5
Porto San Giorgio 5
Rio de Janeiro 5
Tandil 5
Torino 5
Andover 4
Baotou 4
Brno 4
Chengdu 4
Chicago 4
Lappeenranta 4
London 4
Moscow 4
Padova 4
Phoenix 4
Rome 4
Taizhou 4
Terni 4
Xian 4
Caxias do Sul 3
Curitiba 3
Juiz de Fora 3
Jülich 3
Layyah 3
Pune 3
Rouen 3
Seattle 3
Tashkent 3
Tokyo 3
Totale 6.310
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 115
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 111
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 103
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 100
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 99
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 98
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 96
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 96
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 94
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 94
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 94
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 92
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 92
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 91
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 91
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 90
Targeting tumor-related immunosuppression for cancer immunotherapy. 90
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 89
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 88
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 88
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 88
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 88
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 87
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 87
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 86
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 86
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 86
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 86
Interleukin-30 Promotes Breast Cancer Growth and Progression 86
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 85
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 85
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 85
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 85
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 85
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 84
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 83
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 83
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 83
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 83
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 82
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 82
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 82
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 81
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 81
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 81
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 80
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 80
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 80
The role of B lymphocytes and NK cells in cardiac allograft rejection. 80
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 80
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 80
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 79
Neutrophils in anti-cancer immunological strategies: old players in new games 79
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 79
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 79
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 78
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 78
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 78
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 77
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 77
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 77
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 77
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 76
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 76
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 76
The Quilty Effect: an actor in search of a part 76
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 76
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 75
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 75
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 75
The antitumor potential of Interleukin-27 in prostate cancer 75
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 75
Immunological prevention of a multigene cancer syndrome. 74
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 74
Neutrophils in the antitumoral immune response 74
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 73
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. 73
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 72
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 72
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 72
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 72
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. 71
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 71
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma. 70
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 69
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 69
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 69
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 68
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 68
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 68
Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor. 68
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 67
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 67
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers 67
IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis 67
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 66
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. 66
Immunization in tumor prevention. 66
Mouse tumorigenesis models as an aid to understanding human cancer. 66
EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells 66
Totale 8.059
Categoria #
all - tutte 46.229
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.229


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 0 0 0 0 0 0 0 0 0 0 178 26
2020/2021892 148 4 149 9 97 224 14 6 38 126 19 58
2021/2022585 29 9 8 91 52 16 11 52 40 25 71 181
2022/20232.099 175 212 114 254 222 442 114 142 290 51 54 29
2023/2024791 77 34 48 20 36 246 231 15 1 12 8 63
2024/20251.836 157 318 316 98 45 64 46 155 299 134 204 0
Totale 11.061